Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001172665-06-000396
Filing Date
2006-11-02
Accepted
2006-11-02 17:06:09
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED FILING form10ka.txt 10-K/A 240185
2 SECTION 302 CERTIFICATION ex311.txt EX-31.1 4062
3 SECTION 302 CERTIFICATION ex312.txt EX-31.2 4105
4 SECTION 906 CERTIFICATION ex321.txt EX-32.1 1796
5 SECTION 906 CERTIFICATION ex322.txt EX-32.2 1787
  Complete submission text file 0001172665-06-000396.txt   253584
Mailing Address 101 CONVENTION CENTER DRIVE SUITE 310 LAS VEGAS NV 89109
Business Address 101 CONVENTION CENTER DRIVE SUITE 310 LAS VEGAS NV 89109 702-735-7001
SAMARITAN PHARMACEUTICALS INC (Filer) CIK: 0001057377 (see all company filings)

EIN.: 880431538 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32287 | Film No.: 061183552
SIC: 8731 Services-Commercial Physical & Biological Research